Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Dalfampridine Treatment for Nonarteritic Anterior Ischemic Optic Neuropathy (NAION)

NCT01975324 is registered in ClinicalTrials.gov with Neuro-Ophthalmologic Associates, PC as lead sponsor.

NCT NCT01975324
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01975324 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Dalfampridine Treatment for Nonarteritic Anterior Ischemic Optic Neuropathy (NAION)
Lead sponsor
Neuro-Ophthalmologic Associates, PC
Phase
Phase 4
Overall status
Completed
Start date
July 31, 2013
Completion date
December 31, 2015
Enrollment
20 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

non arteritic ischemic optic neuropathy